Efficacy of human papillomavirus l1 protein vaccines (cervarix and gardasil) in reducing the risk of cervical intraepithelial neoplasia: A meta-analysis

• Published in: International journal of preventive medicine 2017-01, Vol.8 (1), p.44-44
• Main Authors: Haghshenas, Mohammad, Mousavi, Tahoora, Kheradmand, Motahareh, Afshari, Mahdi, Moosazadeh, Mahmood
• Format: Article
• Language: English
• Subjects: Aluminum; Cervical cancer; Cervical intraepithelial neoplasia; Cervix dysplasia; Chinese medicine; Clinical trials; efficacy; Health sciences; Human papillomavirus; Immune system; Infections; L1 protein; Medical research; Meta-analysis; Papillomavirus vaccines; Prevention; Proteins; Quality; Quality control; Research centers; Researchers; Review; Risk reduction; Studies; vaccine; Vaccines; Variance analysis; Womens health
• ISSN: 2008-7802; 2008-8213
• DOI: 10.4103/ijpvm.IJPVM_413_16

Human papillomavirus (HPV) can induce cervical intraepithelial neoplasia (CIN). Vaccination against HPV can play an important role in CIN prevention. This study aims to estimate the efficacy of L1 protein vaccines (Cervarix and Gardasil) in CIN 1, 2, 3 risk reduction using meta-analysis. Relevant articles were identified by two independent researchers searching international databanks. After application of inclusion/exclusion criteria and quality assessment, eligible articles were entered into the final meta-analysis. Inverse variance method and fixed effect model were used to combine the results of the primary studies. The heterogeneity between the results was assessed using Cochrane and I2 indices. Of 11,530 evidence identified during the primary search, three papers were found eligible for meta-analysis, including 7213 participants in the intervention groups and 7170 healthy controls. The efficacy (95% confidence interval) of HPV 6, 11, 16, 18 monovalent and quadrivalent vaccines against CIN 1, CIN 2, and CIN 3 were estimated as of 95% (88-98), 97% (85-99), and 95% (78-99), respectively. This study showed that L1 protein vaccines Cervarix and Gardasil are highly protective vaccines playing an effective role in the prevention of HPV 6, 11, 16, 18 which are responsible for CIN 1, CIN 2, and CIN 3.